ClinicalTrials.gg
Not yet recruitingNCT07588893BAE-CIRCUpdated May 15, 2026

Buerger-Allen Exercises and Peripheral Circulation in Sedentary Office Workers

An interventional study of Buerger-Allen Exercise Program in Sedentary Behavior, Peripheral Circulation and Vascular Function, sponsored by Istanbul Gelisim University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by Istanbul Gelisim University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This study aims to evaluate the acute effects of Buerger-Allen exercises on lower extremity circulation in sedentary office workers. Prolonged sitting is associated with reduced venous return, impaired peripheral circulation, and endothelial dysfunction. Buerger-Allen exercises are simple position-based exercises designed to enhance arterial blood flow, venous return, and tissue perfusion. Thirty-five healthy sedentary adults aged 18 to 45 years will participate in this single-group pretest-posttest clinical trial. Skin surface temperature, capillary refill time, ankle-brachial index, peripheral oxygen saturation, and heart rate will be measured before and after a single 20-minute exercise session. The findings may support the use of Buerger-Allen exercises as a practical, low-cost physiotherapy strategy to improve peripheral circulation and reduce the adverse vascular effects of prolonged sitting.

Read the detailed description

Sedentary behavior and prolonged sitting are associated with impaired venous return, reduced peripheral blood flow, endothelial dysfunction, and increased cardiovascular risk. Office workers who remain seated for extended periods may experience lower extremity discomfort, edema, and early circulatory impairment.

Buerger-Allen exercises are position-based therapeutic exercises that involve sequential elevation, dependency, and horizontal rest of the lower limbs. These exercises are designed to promote arterial inflow, facilitate venous return, and enhance tissue perfusion without requiring specialized equipment. Previous studies have demonstrated beneficial effects in patients with peripheral vascular disease and diabetes, but evidence regarding their acute effects in healthy sedentary adults is limited.

This study will use a quasi-experimental single-group pretest-posttest design to investigate the immediate effects of Buerger-Allen exercises on lower extremity circulation in sedentary office workers. A total of 35 participants aged 18 to 45 years will be recruited from Istanbul Gelisim University. All participants will complete a standardized 20-minute Buerger-Allen exercise protocol.

Primary outcome measures will include skin surface temperature assessed with infrared thermometry, capillary refill time, ankle-brachial index, peripheral oxygen saturation, and heart rate. Measurements will be performed at baseline, immediately after the intervention, and 10 minutes after the intervention.

The study is expected to provide evidence regarding the effectiveness of a simple and low-cost physiotherapy intervention for improving peripheral circulation and preventing the adverse vascular effects associated with prolonged sedentary behavior.

02

Conditions studied

  • Sedentary Behavior
  • Peripheral Circulation
  • Vascular Function

Browse trials for

Keywords

  • Buerger-Allen Exercise
  • Peripheral Circulation
  • Sedentary Behavior
  • Office Workers
  • Capillary Refill Time
  • Ankle-Brachial Index
  • Infrared Thermography
  • Physiotherapy
03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's planned enrollment of 35 is below the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

Istanbul Gelisim University is the lead sponsor of 64 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy sedentary office workers
  • Age between 18 and 45 years
  • Sitting for at least 6 hours per day for work-related activities
  • Not meeting regular physical activity recommendations
  • Willing to participate voluntarily and provide written

Exclusion criteria

Exclusion Criteria:

  • History of peripheral arterial disease, deep vein thrombosis, or other vascular disorders
  • Cardiovascular, neurological, or musculoskeletal conditions that may affect lower extremity circulation or prevent exercise participation
  • Diabetes mellitus
  • Current smoking
  • Pregnancy
  • Use of medications that may significantly affect peripheral circulation
  • Lower extremity injury or surgery within the previous 6 months
  • Participation in regular structured exercise programs
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    Buerger-Allen Exercise Group

    Participants will perform a single standardized 20-minute Buerger-Allen exercise session. Lower extremity circulatory parameters will be assessed before the intervention, immediately after the intervention, and 10 minutes after the intervention.

    Behavioral: Buerger-Allen Exercise Program

Interventions

  • BehavioralBuerger-Allen Exercise Program

    The intervention consists of a standardized Buerger-Allen exercise protocol involving three sequential positions: (1) elevation of the lower limbs above heart level to facilitate venous return, (2) dependency of the lower limbs to promote arterial blood flow, and (3) horizontal supine rest to stabilize circulation. The complete exercise session lasts approximately 20 minutes and is performed once. Lower extremity circulatory parameters are assessed at baseline, immediately after the intervention, and 10 minutes after the intervention.

06

What researchers measure

Primary outcomes

  1. Skin Surface Temperature

    Skin surface temperature measured with an infrared thermometer in degrees Celsius (°C). Higher values indicate increased peripheral blood flow and tissue perfusion.

    Time frame: Baseline, Immediately After Intervention, and 10 Minutes After Intervention

  2. Capillary Refill Time

    Capillary refill time measured in seconds. Shorter times indicate improved peripheral microcirculation and tissue perfusion.

    Time frame: Baseline, Immediately After Intervention, and 10 Minutes After Intervention

Secondary outcomes

  1. Ankle-Brachial Index (ABI)

    Ratio of ankle to brachial systolic blood pressure used to assess lower extremity arterial circulation. Higher values within the normal range indicate better arterial perfusion.

    Time frame: Baseline, Immediately After Intervention, and 10 Minutes After Intervention

  2. Peripheral Oxygen Saturation (SpO₂)

    Oxygen saturation measured by pulse oximetry and expressed as a percentage (%). Higher values indicate improved peripheral oxygenation.

    Time frame: Baseline, Immediately After Intervention, and 10 Minutes After Intervention

  3. Heart Rate

    Heart rate measured by pulse oximetry and expressed in beats per minute (bpm).

    Time frame: Baseline, Immediately After Intervention, and 10 Minutes After Intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available because no formal data-sharing plan has been established for this investigator-initiated academic study.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Sep 2026, 3 months later.

Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 3 months is below that.

Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
May 9, 2026
First posted
May 15, 2026
StartEst.
Jun 1, 2026
Primary completionEst.
Sep 1, 2026
CompletionEst.
Dec 1, 2026
Last update
May 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07588893
Lead sponsor
Istanbul Gelisim University
Responsible party
BUSENUR KARAGÖZ (Lecturer, Istanbul Gelisim University) — Principal investigator
First posted
May 15, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
May 15, 2026

Study contacts

Busenur KARAGÖZ, MSc
Contact
buse.nur97e@gmail.com
+90 534 062 71 24
Gökay ÇAKIROĞLU, PT
Contact
gcakiroglu@gelisim.edu.tr
+90 542 519 42 55
Busenur KARAGÖZ, MSc
principal investigator · İstanbul Gelisim University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion